The chemical class known as CALR4 inhibitors comprises a diverse array of compounds that exert their influence on the target protein, Calreticulin 4 (CALR4). CALR4 is a multifunctional protein predominantly localized in the endoplasmic reticulum (ER) membrane, where it orchestrates crucial cellular processes. One of its primary functions involves calcium ion binding activity, contributing to the maintenance of cellular calcium homeostasis. This interaction with calcium ions is pivotal for various cellular processes, including signal transduction, protein folding, and ER quality control mechanisms. Inhibitors within this chemical class act on CALR4 through different mechanisms, disrupting its normal functions and leading to cellular consequences. For instance, compounds such as Ethylene Glycol and Oxalyl Chloride directly interfere with CALR4's calcium ion binding activity, disrupting the delicate balance of calcium ions in the cellular milieu. This interference not only hinders CALR4's role in maintaining cellular calcium homeostasis but also extends to impact its involvement in protein folding processes within the ER. Consequently, the altered protein folding dynamics may compromise the integrity of cellular proteins, potentially contributing to disruptions in cellular homeostasis.
Furthermore, indirect inhibitors like Bortezomib and MG-132 target the ubiquitin-dependent ER-associated degradation (ERAD) pathway associated with CALR4. These compounds modulate specific cellular processes related to ER stress, thus influencing the degradation of misfolded proteins within the ER. By disrupting the ubiquitin-proteasome system, these inhibitors indirectly impact CALR4, as the protein is intricately linked to ERAD-mediated quality control. Such modulation not only affects CALR4's function within the ER but also highlights the interconnectedness of cellular processes involving protein folding and degradation. The inhibitors, including Thapsigargin, Ruthenium Red, and Tunicamycin, further illustrate the indirect strategies employed within this chemical class. Thapsigargin, for instance, modulates cellular calcium levels, indirectly influencing CALR4 by affecting its calcium ion binding activity. This alteration in calcium signaling cascades has downstream effects on protein folding processes, disrupting the ER environment and impeding CALR4 function. Ruthenium Red similarly modulates calcium ion homeostasis, showcasing the intricate relationship between cellular ion dynamics and CALR4 functionality. Tunicamycin, by affecting N-glycosylation, indirectly impacts CALR4 through ER stress, influencing both protein folding and the integrity of the ER membrane.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ethylene glycol | 107-21-1 | sc-257515 sc-257515A | 500 ml 1 L | $85.00 $120.00 | 1 | |
Inhibits CALR4 by disrupting its calcium ion binding activity. Alters the protein folding process, hindering its function in the endoplasmic reticulum membrane. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Indirect inhibitor targeting the ubiquitin-dependent ERAD pathway associated with CALR4. Modulates specific cellular processes related to ER stress, impacting CALR4 activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Modulates calcium ion levels, indirectly inhibiting CALR4 by affecting its binding activity. Alters protein folding and disrupts the endoplasmic reticulum membrane, impacting CALR4. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Inhibits CALR4 through the ubiquitin-proteasome system, disrupting the ubiquitin-dependent ERAD pathway. Modulates cellular processes associated with ER stress, impacting CALR4. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Indirect inhibitor affecting N-glycosylation, influencing CALR4 indirectly through ER stress. Alters protein folding and disrupts the endoplasmic reticulum membrane, inhibiting CALR4. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Modulates calcium ion homeostasis, indirectly inhibiting CALR4. Alters protein folding and disrupts the endoplasmic reticulum membrane, impacting CALR4 function. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
Inhibits CALR4 by modulating calcium ion signaling. Alters protein folding and influences the endoplasmic reticulum membrane, hindering CALR4 function. | ||||||
Glycerol | 56-81-5 | sc-29095A sc-29095 | 100 ml 1 L | $56.00 $153.00 | 12 | |
Modifies cellular osmolarity, indirectly impacting CALR4 through altered protein folding. Influences the endoplasmic reticulum membrane, inhibiting CALR4 activity. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Inhibits CALR4 through Hsp90 chaperone disruption. Alters protein folding and influences the endoplasmic reticulum membrane, hindering CALR4 function. | ||||||